CME Group to launch European rapeseed oil futures

Reuters
18 Mar
CME Group to launch European rapeseed oil futures

PARIS, March 18 (Reuters) - Financial markets operator CME Group CME.O said on Tuesday that it plans to launch cash-settled futures for European rapeseed oil next month, using an Argus Media index for Dutch prices.

The new product will start trading on April 28, subject to regulatory approval, through CME's Chicago Board of Trade exchange, the company said in a notice on its website.

The futures will consist of consecutive monthly contracts, starting with May 2025, and trade in lots of 20 metric tons, it said.

Rapeseed oil is a byproduct of rapeseed, the most produced oilseed crop in Europe.

The launch marks a fresh attempt by CME, whose U.S. corn, wheat and soybean futures are global price benchmarks, to expand in the European grain market.

The U.S. group scrapped a European Union wheat futures contract after failing to attract volumes against Euronext's ENX.PA wheat market BL2c1, while it suspended trading in its Black Sea grain futures following Russia's invasion of Ukraine.

Euronext's rapeseed futures COMc1 are a price benchmark in Europe but the exchange discontinued related futures for rapeseed oil and meal that had failed to trade actively.

At the same time, CME and Euronext last year jointly launched contracts to allow trading of price spreads between their respective wheat futures.

(Reporting by Gus Trompiz and Sybille de La Hamaide; Editing by Susan Fenton)

((gus.trompiz@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10